http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022304933-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e2d17db066c8dce859c3322182d2af4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5365
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2021-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f25ca91e401346045db627214f09039d
publicationDate 2022-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2022304933-A1
titleOfInvention Lyophilized powder of latamoxef sodium for injection and lyophilization method thereof
abstract A lyophilized powder of latamoxef sodium for injection and a lyophilization method thereof are provided. The lyophilized powder of latamoxef sodium for injection includes the following raw materials by weight: 20˜40 parts of latamoxef sodium, 8˜15 parts of lyophilized adjuvant, 6˜18 parts of excipient and 30˜55 parts of water; by optimizing a raw material process thereof, the present disclosure prepares lyophilized adjuvant and performs twice drying, so that the raw material has stable quality, less impurities, high purity, less adverse reactions and high efficacy; at the same time, the preparation process is innovated and improved to reduce a preparation temperature and ensure stable quality of a drug solution.
priorityDate 2021-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12856838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3511295
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP12614
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4322590
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C946
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB6ZKM3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4706951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15885
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ03506
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO93785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB9K7M5
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449164853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4586518
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID821201
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP29091
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8GVD0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9FYS3
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316

Total number of triples: 50.